News & Press

Successful FDA Inspection for Plankstadt

Jul 09, 2018
News > CordenPharma Plankstadt Receives Successful FDA Inspection

News > CordenPharma Plankstadt Receives Successful FDA Inspection


CordenPharma is pleased to announce that in July 2018 our CordenPharma Plankstadt (DE) manufacturing facility completed a general inspection conducted by the US FDA. The facility received a successful response with no FDA 483 observations reported.

Frank Haehner, Managing Director of CordenPharma Plankstadt comments, “We are pleased with the outcome of the FDA Inspection in July 2018 as it reflects our high level of professionalism, authenticity and cGMP regulatory compliance, which fully lives up to the laws and regulations of the United States Authorities.”